INTRODUCTION
============

Acute cholecystitis (AC) is a common disease that presents with episodic pain in the epigastrium or right upper quadrant (RUQ) of the abdomen. Following the first successful laparoscopic cholecystectomy (LC) by Mouret in 1987, LC has become the primary choice for managing most benign gallbladder (GB) diseases \[[@b1-kjim-2016-209]\]. Recently, early LC has been recommended for AC based on the results of two randomized studies. Specifically, failure of initial conservative treatment is reported in up to 26% of cases, and early cholecystectomy has been shown to reduce total hospital stay despite its high conversion rate \[[@b2-kjim-2016-209]-[@b4-kjim-2016-209]\].

Percutaneous cholecystostomy (PC) is used as an immediate treatment for the management of AC in elderly or critically ill patients, because emergency cholecystectomy increases the risk of mortality \[[@b5-kjim-2016-209]\]. PC is regarded as a safe and effective procedure for AC and can be performed with a high degree of technical success \[[@b6-kjim-2016-209],[@b7-kjim-2016-209]\]. Elective delayed cholecystectomy after PC may lower the rates of conversion and complication in patients with complicated AC \[[@b8-kjim-2016-209]-[@b10-kjim-2016-209]\]. Most studies have reported that PC is an effective treatment for complicated AC due to empyema, gangrene, perforation, pericholecystic abscess formation, peritonitis, or sepsis \[[@b11-kjim-2016-209]\].

According to the recently issued Tokyo guidelines, PC is recommended for patients with moderate AC with severe local inflammation and for those with severe AC \[[@b12-kjim-2016-209],[@b13-kjim-2016-209]\]. However, only a few studies have addressed the efficacy of PC based on AC severity assessment. As the indications for PC in the setting of AC are still not established, it is difficult to make decisions regarding preoperative PC with subsequent cholecystectomy or early cholecystectomy without PC in clinical practice. The aim of this study was to assess the role of PC in evaluating clinical parameters and outcomes, complications related to PC and operation, and conversion rates of open cholecystectomy in patients with AC classified according to severity grade.

METHODS
=======

Study group
-----------

Patients who underwent LC without preoperative LC or preoperative PC with subsequent elective LC due to AC between January 2008 and October 2010 at Hallym University Sacred Heart Hospital were enrolled. Exclusion criteria were biliary drainage procedures other than PC, such as percutaneous transhepatic biliary drainage, nasobiliary drainage, or biliary stent placement for combined common bile duct stones, and hepatobiliary malignancy. All patients were classified into three groups according to the severity grade of the Tokyo guidelines for AC: grade I (mild), grade II (moderate), and grade III (severe) ([Table 1](#t1-kjim-2016-209){ref-type="table"}) \[[@b13-kjim-2016-209]\]. Each group was further classified into two subgroups of those with or without preoperative PC. This study was approved by the Institutional Review Board of Hallym University Sacred Heart Hospital. The IRB approved a waiver of the requirements to obtain informed consent for this study.

Diagnosis of acute cholecystitis
--------------------------------

The diagnosis of AC was made preoperatively from the characteristic patient's clinical presentation (RUQ abdominal pain, fever, Murphy's sign), laboratory findings (elevated white blood cell \[WBC\] count or C-reactive protein \[CRP\] level), and imaging findings (thickened GB wall, pericholecystic fluid collection, enlarged GB) \[[@b13-kjim-2016-209]\]. After establishing a diagnosis of AC, all patients were started on initial medical management comprising nothing by mouth, intravenous fluid, intravenous antibiotics, and analgesics.

Percutaneous cholecystostomy and operation
------------------------------------------

PC was performed by a single experienced interventional radiologist under ultrasound and fluoroscopic guidance. The decision to perform PC was made at the physician's discretion based on the patient's clinical condition, response to medical treatment for AC, and surgical risk related to any underlying comorbidities. A 21-gauge Chiba needle (Precision Needle Manufacturing Co., Suwon, Korea) was advanced into the GB through the liver under 1% lidocaine local anesthesia. After placing a guidewire and dilating the track, an 8.5-Fr pigtail catheter (Multipurpose Drainage Catheter, Sungwon Medical, Cheongju, Korea) was positioned in the GB, and bile was aspirated for culture. Cholangiograms were performed to confirm the correct position of the pigtail catheter within the GB. LC was performed on all patients by two experienced hepatobiliary surgeons.

Data collection
---------------

The following data were collected (1) demographic parameters comprising age, sex, preoperative American Society of Anesthesiologists (ASA) score, and comorbid diseases; (2) clinical parameters: body temperature, presence of abdominal pain, and RUQ tenderness; (3) laboratory findings: WBC count, CRP level, and liver enzymes; (4) imaging findings: GB distension, GB wall thickening, pericholecystic fluid collection, GB stone or sludge, sonographic Murphy's sign, and GB wall disruption; (5) clinical outcome and perioperative complications; and (6) operative time, rates of conversion to open surgery, preoperative and overall hospital stay, and postoperative pathological findings.

Clinical outcomes
-----------------

Clinical outcomes including clinical improvement after PC, operative time, conversion rate to open cholecystectomy, complication rates after surgery, and length of hospital stay were analyzed to assess the efficacy of preoperative PC for the management of AC according to disease severity grade.

Pathological classification
---------------------------

All preoperative diagnoses were confirmed by histopathological examination of removed specimens. Pathology analysis and cholecystitis grading were conducted by assessing inflammatory cell infiltration, mucosal changes, abscess formation, and wall destruction. AC findings consisted of neutrophil infiltration, edema or ulceration of the mucosal layer, and necrosis. All pathological examinations were reviewed by two experienced pathologists.

Statistical analysis
--------------------

Chi-square test was used for univariate analyses to compare baseline characteristics, procedural factors for PC, and clinical outcomes between patients with and without preoperative PC. Multivariate logistic regression analysis was conducted to ascertain the odds ratio of PC related procedural factors.

Additional univariate analyses were performed to compare baseline characteristics, baseline procedural factors, and clinical outcomes among patient groups with or without preoperative PC according to the severity grade of AC.

Statistical comparisons for continuous parameters such as length of hospital stay and operative time among groups were made using independent *t* tests. A *p* \< 0.05 was considered statistically significant. All statistical analyses were performed with SPSS version 18.0 (SPSS Inc., Chicago, IL, USA).

RESULTS
=======

Baseline characteristics and clinical outcomes between patient groups with and without percutaneous cholecystostomy
-------------------------------------------------------------------------------------------------------------------

A total of 325 patients were enrolled in this study. The mean patient age was 57.4 ± 16.3, and the study population was 55.7% males (181/325). Among the patients enrolled in this study, 131 (40.3%) underwent preoperative PC. The demographic data of the two patient groups with or without PC are summarized in [Table 2](#t2-kjim-2016-209){ref-type="table"}. Advanced age over 65 years, history of abdominal surgery, and higher ASA score were significantly more frequent in the PC group. Males were slightly more predominate in both groups, but the difference was not significant. The mean duration of symptoms to admission was 2.7 days for each group, which did not correlate with the use of PC. WBC count (*p* \< 0.001) and CRP level (*p* \< 0.001) were significantly higher in the PC group. However, the levels of alanine aminotransferase, alkaline phosphatase, and total bilirubin were not different between groups ([Table 2](#t2-kjim-2016-209){ref-type="table"}).

According to multivariate analysis, the independent factors that correlated with use of preoperative PC for AC were advanced age over 65 years (*p* \< 0.001), a history of abdominal surgery (*p* = 0.023), a higher ASA score (*p* = 0.015), WBC count (*p* = 0.023), and CRP level (*p* = 0.013) ([Table 3](#t3-kjim-2016-209){ref-type="table"}).

Overall hospital stay (11.0 ± 5.1 days vs. 15.6 ± 10.3 days, *p* \< 0.001), preoperative hospital stay (5.9 ± 3.7 days vs. 8.5 ± 5.0 days, *p* \< 0.001), and postoperative hospital stay (5.4 ± 4.2 days vs. 7.1 ± 7.4 days, *p* = 0.007) were significantly longer in patients who underwent PC than in those who did not. In addition, the mean operative time was significantly longer in patients who underwent PC than in those who did not (99.0 ± 41.3 minutes vs. 117.0 ± 43.6 minutes, *p* \< 0.001). There was no significant difference in the conversion rate to open cholecystectomy between groups ([Table 4](#t4-kjim-2016-209){ref-type="table"}).

Comparisons of clinical results in patient groups according to severity grade
-----------------------------------------------------------------------------

All patients were classified into three groups according to the severity grade of AC; 184 patients (57%) were classified in the grade I group, 135 patients (42%) were grade II, and the remaining five patients (1%) were grade III. Fifty-one patients (27.7%) from the grade I group, 75 patients (55.5%) from the grade II group, and five patients (100%) from the grade III group underwent preoperative PC. Statistical analysis could not be performed for the grade III group because all five patients in that group received PC before LC.

PC was successful in all patients for whom the procedure was performed, and there were no procedure-related major complications or cases of mortality. All patients except two showed clinical improvement after PC on the basis of resolution of symptoms and signs within 72 hours. One patient in the grade I group underwent early operation due to persistent RUQ pain, and one patient in the grade II group developed a liver abscess.

Clinical parameters and outcomes were analyzed in each of the severity groups. In both the grade I and II groups, patients who underwent PC were significantly older than those who did not (49.6 ± 14.5 years vs. 65.6 ± 11.38 years, *p* \< 0.001; 57.6 ± 18.1 years vs. 65.0 ± 13.7 years, *p* = 0.01, respectively). There were significantly more patients older than 65 years who underwent PC in both the grade I and II groups. Additionally, the number of patients with higher ASA score (ASA ≥ II) was significantly higher among those who underwent PC. Patients with PC had more comorbid diseases such as hypertension, DM, coronary artery disease, cerebrovascular disease, COPD, and chronic kidney disease. The time interval to PC from admission was less than 24 hours in most patients with PC of any grade.

With respect to laboratory findings, WBC count was significantly higher in patients with PC, especially in the grade II group (*p* \< 0.001). CRP level was significantly higher in patients who underwent PC in the grade I and II groups (*p* = 0.003 and *p* = 0.007, respectively). After performing PC, mean WBC count and CRP level decreased significantly within 2 to 5 days. There were no significant differences in terms of alanine aminotransferase, alkaline phosphatase, or total bilirubin between groups ([Table 5](#t5-kjim-2016-209){ref-type="table"}).

The length of overall hospital stay was significantly shorter for patients who did not undergo PC than for those who did in both the grade I and II groups (*p* \< 0.001 and *p* = 0.003, respectively). The length of preoperative hospital stay was also significantly shorter in patients who did not undergo PC than in those who did in both the grade I and II groups (*p* = 0.001 and *p* = 0.002, respectively). There were no significant differences among groups in terms of the length of postoperative hospital stay.

In the grade I group, the mean operative time was significantly shorter in patients who did not undergo PC than in those who did undergo PC (*p* = 0.034); however, there was no significant difference in mean operative time in the grade II group (*p* = 0.074) ([Table 6](#t6-kjim-2016-209){ref-type="table"}).

The mean time interval to operation after PC was approximately 1 week for all grades: 7.1 days for the grade I group, 7.8 days for the grade II group, and 6.6 days for the grade III group.

Conversion rate to open surgery and complications
-------------------------------------------------

Conversion to open cholecystectomy was necessary in 13 patients (4%): three patients in the grade I group, nine patients in the grade II group, and one patient in the grade III group. The differences in the rates of conversion were not significant among groups. All of the patients who required conversion had severe inflammation and adhesions obscuring the plane of dissection and anatomy around Carlot's triangle.

There were no cases of postoperative mortality in any of the three groups. Three patients (1%) developed postoperative complications, which did not vary significantly between groups. In the grade I group, one patient who did not undergo PC had transient biliary leakage. In the grade II group, one patient who received PC experienced transient biliary leakage, while another patient who did not undergo PC had bleeding at the operation site.

DISCUSSION
==========

The results of the present study demonstrated that the mean length of hospital stay and operative time in patients with mild and moderate AC were significantly longer for those who underwent preoperative PC, without any difference in the rates of conversion to open surgery or postoperative complications.

According to the Tokyo guidelines proposed in 2013, the severity of AC is classified into three grades: mild (grade I), moderate (grade II), and severe (grade III). PC is recommended for patients with moderate (grade II) disease who do not respond to conservative treatment and those with severe (grade III) disease \[[@b12-kjim-2016-209],[@b14-kjim-2016-209]\]. In clinical practice, the decision to perform PC is usually made based on the patient's poor condition for general anesthesia due to comorbidities or shock, suspected severe AC, or persistent symptoms with impaction of stones in the GB neck \[[@b15-kjim-2016-209],[@b16-kjim-2016-209]\]. Because there are no established criteria or guidelines for determining when to perform PC before LC, a combination of physician's discretion and resource constraints of the hospital may affect the decision to perform PC before LC.

PC is an effective tool with a high success rate and low morbidity and facilitates safe subsequent surgical treatment, especially for LC \[[@b10-kjim-2016-209]\]. Some surgeons prefer preoperative PC before LC based on the results of previous studies indicating that elective cholecystectomy after PC may lower the conversion and complication rates of patients with complicated AC \[[@b8-kjim-2016-209]-[@b10-kjim-2016-209],[@b17-kjim-2016-209]\]. However, several recent studies have reported that PC is associated with increased 30-day mortality, higher odds of death, higher morbidity rates, and higher total costs compared with cholecystectomy \[[@b18-kjim-2016-209]-[@b20-kjim-2016-209]\].

The recommendation for PC in cases of severe (grade III) AC is generally accepted in clinical practice. In some institutes, preoperative PC may be performed based on the physician's preference or as an arbitrary indication based on the hospital's policy for delayed surgery rather than according to AC severity grade, especially for moderate or mild AC. In the present study, PC was performed in about 27% of patients in the mild (grade I) group and 55% of patients in the moderate (grade II) group. In addition, with respect to moderate AC, the decision to perform PC may depend largely on the patient's age, comorbidities, and ASA score rather than their response to initial medical management.

PC was performed in patients with advanced age over 65 years, comorbidities, and higher ASA score in both mild and moderate AC groups. However, in the moderate AC group, PC was performed not only for patients who did not respond to conservative management, but also for those who responded to initial medical management. In this case, the decision to perform PC depended largely on the physician's discretion.

According to previous studies, factors such as older age, male sex, prolonged duration of symptoms, and increased inflammatory changes such as WBC and CRP are significant predictors of severe AC and treatment with PC \[[@b21-kjim-2016-209]\]. However, based on the results of present study, preoperative PC in cases of mild or moderate AC prolonged the total hospital stay and operative time without any additional benefit to clinical outcomes. Although costs were not specifically evaluated in this study, these factors were likely associated with increased total medical expenditures. These results are comparable with those of previous studies \[[@b3-kjim-2016-209],[@b4-kjim-2016-209],[@b22-kjim-2016-209]\].

Taken together, the results of the present study suggest that early LC be recommended for patients with uncomplicated AC who do not have indications for PC. Thus, PC should be reserved for patients who are not candidates for early LC.

According to subgroup analysis, preoperative and overall hospital stay were significantly longer in patients who underwent PC than in those who did not for both the mild and moderate AC groups. However, there were no significant differences between groups with respect to length of postoperative hospital stay. Rather, patients who underwent PC contributed to the longer preoperative hospital stay in the mild and moderate AC groups. The longer preoperative stay in the PC group may have been due to the time required to perform PC as well as improvement in the condition of patients before surgery. Furthermore, subgroup analysis showed that the mean operative time was significantly longer in patients who underwent PC in both the mild and moderate AC groups. The prolonged operative time in the patients with PC was comparable with previous studies \[[@b16-kjim-2016-209],[@b22-kjim-2016-209],[@b23-kjim-2016-209]\], which may have been due to the presence of dense adhesions, a thickened GB wall, a tendency for bleeding at the site of the operation, and difficulty in identifying anatomical structures during surgery. In contrast, other studies have reported longer operative times in patients who did not undergo PC \[[@b9-kjim-2016-209],[@b22-kjim-2016-209]\].

There were several limitations of the present study. First, this study was retrospective in nature and thus had several innate limitations. In addition, some medical records of clinical presentations may not have been completely documented. Another limitation of this study was that, in each subgroup, physicians decided to preferentially perform PC in patients with old age, comorbidities, and higher ASA score, despite similar severity grades. Further, the individual indications for PC may have varied among the treating physicians. Together, this may have introduced selection bias and influenced the clinical outcomes of the study. This study was also limited by the small number of severe (grade III) patients enrolled, and the fact that all of these patients underwent PC. Therefore, it was not possible to compare outcomes and perform statistical analyses for the grade III group. Lastly, although the present study adopted the revised Tokyo guidelines for severity grading, these guidelines have their own limitations and may not represent all clinical conditions for patients with AC \[[@b24-kjim-2016-209]\].

There are no randomized controlled studies evaluating the outcome of preoperative PC versus early cholecystectomy for AC according to severity grade. Thus, the efficacy of PC should be investigated according to severity of AC. Further accumulation of data is needed to establish a set of unified guidelines regarding the use preoperative PC before LC in patients with AC.

In conclusion, we did not identify a significant benefit of preoperative PC for the management of either mild or moderate AC. With respect to patients with mild and moderate AC, the mean length of hospital stay and operative time were significantly longer for the subgroup of patients who underwent PC. There was no significant difference with respect to clinical outcomes or perioperative morbidities in patients who underwent PC and those who did not. Therefore, preoperative PC should be reserved for only selected patients with mild or moderate AC. More prospective study is needed to establish clear indication of PC in moderate AC to avoid unnecessary PC in clinical practice.

KEY MESSAGE
===========

1\. We did not identify a significant benefit of preoperative percutaneous cholecystostomy for the management of either mild or moderate acute cholecystitis.

2\. Percutaneous cholecystostomy should be reserved for only selected patients with mild or moderate acute cholecystitis.

No potential conflict of interest relevant to this article was reported.

###### 

TG13 severity grading for acute cholecystitis

  Grade                                                                                                                                                  Criteria
  ------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Grade I (mild) acute cholecystitis                                                                                                                     Does not meet the criteria of ''Grade III'' or ''Grade II'' acute cholecystitis. Grade I can also be defined as acute cholecystitis in a healthy patient with no organ dysfunction and mild inflammatory changes in the gallbladder, making cholecystectomy a safe and low-risk op erative procedure
  Grade II (moderate) acute cholecystitis                                                                                                                Associated with any one of the following conditions:
  1\. Elevated white blood cell count (\> 18,000/mm^3^)                                                                                                  
  2\. Palpable tender mass in the right upper abdominal quadrant                                                                                         
  3\. Duration of complaints \> 72 hours                                                                                                                 
  4\. Marked local inflammation (gangrenous cholecystitis, pericholecystic abscess, hepatic abscess, biliary peritonitis, emphysematous cholecystitis)   
  Grade III (severe) acute cholecystitis                                                                                                                 Associated with dysfunction in any one of the following organs/systems:
  1\. Cardiovascular dysfunction                                                                                                                         
   Hypotension requiring treatment with dopamine ≥ 5 µg/kg/min or any dose of norepinephrine                                                             
  2\. Neurological dysfunction                                                                                                                           
   Decreased level of consciousness                                                                                                                      
  3\. Respiratory dysfunction                                                                                                                            
   PaO~2~/FiO~2~ ratio \< 300                                                                                                                            
  4\. Renal dysfunction                                                                                                                                  
   Oliguria, creatinine \> 2.0 mg/dL                                                                                                                     
  5\. Hepatic dysfunction                                                                                                                                
   PT-INR \> 1.5                                                                                                                                         
  6\. Hematological dysfunction                                                                                                                          
   Platelet count \< 100,000/mm^3^                                                                                                                       

PaO~2~, arterial partial pressure of oxygen; FiO~2~, fraction of inspired oxygen; PT-INR, prothrombin time-international normalized ratio.

###### 

Baseline and clinical characteristics of patient groups according to PC

  Characteristic                   Overall         Without PC      With PC         *p* value
  -------------------------------- --------------- --------------- --------------- -----------
  Number                           325 (100)       194 (59.7)      131 (40.3)      
  Age                              57.4 ± 16.3     52.1 ± 16.17    65.0 ± 13.19    
   \> 65 yr                        123 (37.8)      45 (23.2)       78 (59.5)       \< 0.001
  Sex                                                                              0.357
   Male                            181 (55.7)      104 (53.6)      77 (58.8)       
   Female                          144 (44.3)      90 (46.4)       54 (41.2)       
  Previous abdominal surgery       41 (12.6)       16 (8.2)        25 (19.1)       0.004
  Duration of symptom, day         2.7 ± 2.2       2.7 ± 2.3       2.7 ± 2.0       0.981
  ASA score                                                                        \< 0.001
   I                               101 (31.1)      85 (43.8)       16 (12.2)       
   II                              178 (54.8)      98 (50.5)       80 (61.1)       
   III                             44 (13.5)       11 (5.7)        33 (25.2)       
   IV                              2 (0.6)         0               2 (1.5)         
  WBC, × 10^3^ cells/mm^3^         12.5 ± 8.6      10.9 ± 9.8      14.9 ± 5.6      \< 0.001
  Platelets, × 10^3^ cells/mm^3^   251.5 ± 81.8    252.7 ± 82.6    245.9 ± 85.2    0.473
  ALT, IU/L                        72.1 ± 126.5    82.1 ± 135.3    57.2 ± 111.1    0.071
  TB, mg/dL                        1.5 ± 1.5       1.5 ± 1.7       1.4 ± 1.0       0.645
  ALP, IU/L                        236.1 ± 155.3   232.8 ± 158.1   241.0 ± 151.4   0.644
  CRP, mg/L                        86.2 ± 99.2     57.7 ± 80.9     130.7 ± 108.7   
  Elevated CRP                     172 (52.9)      86 (44.3)       86 (65.6)       \< 0.001

Values are presented as number (%) or mean ± SD.

PC, percutaneous cholecystostomy; ASA, American Society of Anesthesiologists; WBC, white blood cell; ALT, alanine aminotransferase; TB, total bilirubin; ALP, alkaline phosphatase; CRP, C-reactive protein.

###### 

Multivariate analysis of preoperative percutaneous cholecystostomy in acute cholecystitis

  Variable                     OR (95% CI)         *p* value
  ---------------------------- ------------------- -----------
  Age (\> 65 yr)               3.66 (1.79--7.49)   \< 0.001
  Previous abdominal surgery   3.03 (1.17--7.88)   0.023
  ASA score                    2.11 (1.15--3.87)   0.015
  Elevated WBC                 2.33 (1.13--4.84)   0.023
  High CRP                     2.94 (1.25--6.92)   0.013

OR, odds ratio; CI, confidence interval; ASA, American Society of Anesthesiologists; WBC, white blood cell; CRP, C-reactive protein.

###### 

Clinical outcomes of patient groups according to PC

  Variable                          Overall        Without PC    With PC        *p* value
  --------------------------------- -------------- ------------- -------------- -----------
  Number                            325            194           131            
  Hospital stay, day                                                            
   Overall                          12.9 ± 8.0     11.0 ± 5.1    15.6 ± 10.3    \< 0.001
   Preoperative                     7.0 ± 4.4      5.9 ± 3.7     8.5 ± 5.0      \< 0.001
   Postoperative                    6.1 ± 5.8      5.4 ± 4.2     7.1 ± 7.4      0.007
  Operative time, min               106.3 ± 43.1   99.0 ± 41.3   117.0 ± 43.6   \< 0.001
  Conversion rate to open surgery   13 (4.0)       5 (2.5)       8 (6.1)        0.111

Values are presented as mean ± SD or number (%).

PC, percutaneous cholecystostomy.

###### 

Clinical characteristics of patients according to severity grade of acute cholecystitis

  Characteristic                   Grade I (n = 184)   Grade II (n = 135)   Grade III^[a](#tfn1-kjim-2016-209){ref-type="table-fn"}^ (n = 5)                                                                   
  -------------------------------- ------------------- -------------------- ------------------------------------------------------------------ --------------- --------------- ---------- ---- --------------- ----
  Number                           133 (72.3)          51 (27.7)                                                                               60 (44.4)       75 (55.6)                  0    5 (100)         
  Age                              49.6 ± 14.5         65.6 ± 11.3          \< 0.001                                                           57.6 ± 18.1     65.0 ± 13.7     0.010           60.2 ± 22.1     NA
   \> 65 yr                        22 (16.5)           30 (58.8)            \< 0.001                                                           23 (37.7)       45 (60.0)       0.015           3               NA
  Male sex                         72 (54.1)           34 (66.7)            0.084                                                              32 (52.5)       40 (53.3)       1.000           3 (60.0)        NA
  ASA                                                                       \< 0.001                                                                                           \< 0.001                        NA
   I                               63 (47.4)           7 (13.7)                                                                                22 (36.1)       9 (12.0)                   \-   \-              
   II                              64 (48.1)           37 (72.5)                                                                               34 (55.7)       41 (54.7)                  \-   2 (40)          
   III                             6 (4.5)             7 (13.7)                                                                                5 (8.2)         23 (30.7)                  \-   3 (60)          
   IV                              0                   0                                                                                       0               2 (2.7)                    \-   \-              
  Comorbidities                    36 (27.1)           28 (54.9)            \< 0.001                                                           22 (36.1)       39 (52.0)       0.063           3               NA
  WBC, × 10^3^ cells/mm^3^         10.6 ± 11.4         12.0 ± 3.8           0.412                                                              11.5 ± 4.8      16.6 ± 5.7      \< 0.001        15.5 ± 7.8      NA
  Platelets, × 10^3^ cells/mm^3^   246.6 ± 79.1        245.9 ± 64.8         0.954                                                              265.8 ± 88.9    250.3 ± 94.3    0.331           177.8 ± 111.8   NA
  ALT, IU/L                        79.5 ± 136.0        52.6 ± 91.4          0.194                                                              87.5 ± 134.5    62.8 ± 126.1    0.273           20.0 ± 8.7      NA
  TB, IU/L                         1.5 ± 1.7           1.3 ± 0.9            0.557                                                              1.5 ± 1.7       1.5 ± 1.0       0.945           1.2 ± 0.6       NA
  ALP, IU/L                        214.7 ± 136.4       224.8 ± 147.3        0.662                                                              272.1 ± 192.7   256.3 ± 157.6   0.600           178.6 ± 43.4    NA
  CRP, mg/L                        33.2 ± 51.7         72.7 ± 69.5          0.003                                                              105.5 ± 103.9   162.9 ± 113.0   0.007           192.4 ± 127.5   NA

Values are presented as number (%) or mean ± SD.

PC (--), without percutaneous cholecystostomy; PC (+), with percutaneous cholecystostomy; NA, not applicable; ASA, American Society of Anesthesiologists; WBC, white blood cell; ALT, alanine aminotransferase; TB, total bilirubin; ALP, alkaline phosphatase; CRP, C-reactive protein.

Statistical analysis for grade III group was not performed because all of the patients underwent preoperative PC.

###### 

Clinical outcomes of patients according to severity grade of acute cholecystitis

  Variable                          Grade I (n = 184)   Grade II (n = 135)   Grade III (n = 5)                                                           
  --------------------------------- ------------------- -------------------- ------------------- -------------- -------------- ------- ---- ------------ ----
  Number                            133 (72.3)          51 (27.7)                                60 (44.4)      75 (55.6)              0    5 (100)      
  Hospital stay                                                                                                                                          
   Preoperative                     5.8 ± 3.3           8.2 ± 4.6            0.001               6.0 ± 4.4      8.8 ± 5.2      0.002   \-   7.6 ± 4.3    NA
   Postoperative                    4.9 ± 2.6           5.4 ± 2.4            0.163               6.3 ± 6.4      8.1 ± 9.4      0.216   \-   8.6 ± 4.6    NA
   Overall                          10.7 ± 4.4          13.7 ± 5.75          \< 0.001            11.8 ± 6.5     16.9 ± 12.5    0.003   \-   16.2 ± 7.6   NA
  Operative time, min               94.6 ± 36.4         107.3 ± 33.5         0.034               108.5 ± 49.5   123.9 ± 48.9   0.074   \-   114 ± 35.6   NA
  Conversion rate to open surgery   2 (1.5)             1 (2.0)              1.000               3 (5.0)        6 (8.0)        0.731   \-   1 (20)       NA
  Postoperative complications       1 (0.8)             0                    \-                  1 (1.7)        1 (1.3)        \-      \-   0            NA

Values are presented as number (%) or mean ± SD.

PC (--), without percutaneous cholecystostomy; PC (+), with percutaneous cholecystostomy; NA, not applicable.
